UNLOCKING

SURGICAL INNOVATION

Dr. Sean Christie, QEII neurosurgeon

$3 MILLION

CAMPAIGN COMPLETED FOR SPINAL ROBOT AND ACCOMPANYING RESEARCH

Thanks to QEII Foundation donors, the QEII was the first hospital in Canada to perform a patient procedure using the MAZOR X spinal robot and the only health centre in Atlantic Canada to house the technology.

This advanced robotics technology enhances surgical precision which can result in shorter hospital stays, quicker recoveries and fewer revision surgeries — all of which have a transformational impact on patient care and wait times.

Having this spinal robotics technology at the QEII really adds to the development of a robotics centre of excellence and gives us the opportunity to advance care locally and lead national research and training around innovations in spinal robotics. No question, this technology is changing lives. – Dr. Sean Christie

QEII surgical staff during a training session with the MAZOR X spinal robot.

This game-changing technology wouldn’t be a reality without Irving Shipbuilding Inc., who contributed $1 million to the project. 

Their lead gift is revolutionizing spinal surgeries at the QEII and igniting research that will set standards on a global stage. 

In recognition of Irving Shipbuilding Inc.’s generous gift, patients and families accessing spinal surgery each year will be cared for in the new Irving Shipbuilding Spinal Robot Surgical Suite.

Funding Canada’s first spinal robot for patient care is a prime example of our $100-million We Are campaign at work and the role philanthropy plays in elevating health care to new heights.  

Group 3 Created with Sketch.

QEII Health Sciences Centre Foundation

5657 Spring Garden Road
Park Lane Mall, Suite 3005
Halifax, Nova Scotia
B3J 3R4

Phone: 902 334 1546
Toll Free: 1 888 428 0220
Fax: 902 492 8094
Email: [email protected]

Charitable Business No:
88646 3496 RR0001

©2025 QEII Foundation | Privacy Policy

$2.1 MILLION TO ESTABLISH ATLANTIC CANADA’S FIRST CAR-T THERAPY LAB $200,000 GRANTED TO QEII RESEARCHERS THROUGH THE INNOVATION CATALYST FUND